GlassScriptPhysician profile
Amitha Anandula
NPI 1831867365
$1,010.79
in general payments reported to CMS, 2019-2025
12 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $226 · 2023: $68.19 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $232.73 | 2021-2022 | |
| Inspire Medical Systems, INC. | $179.26 | 2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $121.84 | 2025 | Rexulti |
| Esperion Therapeutics, INC. | $121.60 | 2021 | |
| Medtronic, INC. | $117.09 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $115.44 | 2025 | Uzedy |
| Janssen Pharmaceuticals, INC | $44.07 | 2023 | Xarelto |
| Melinta Therapeutics, LLC | $24.12 | 2023 | Orbactiv |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.34 | 2021 | |
| Eisai INC. | $14.72 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.46 | 2021 | |
| Amgen INC. | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amitha Anandula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.